FdaApplication

ANDA 206987

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNATCO PHARMA LTD
application_typeANDA
approval_date2019-04-26

Products (2)

ProductActive ingredientStrengthDosage form
BOSENTANBOSENTAN125MGTABLET;ORAL
BOSENTANBOSENTAN62.5MGTABLET;ORAL

2 products